Analysis of U.S. Patent 10,307,368: Scope, Claims, and Patent Landscape
What Is the Scope of U.S. Patent 10,307,368?
U.S. Patent 10,307,368 covers a novel method of treating specific medical conditions using a defined class of pharmaceutical compounds. The patent claims a composition and process designed to improve efficacy, stability, or bioavailability of the active agent.
The patent claims priority to applications filed in 2017 and was granted on May 28, 2019. It is assigned to a major pharmaceutical company active in the targeted therapeutic area.
Patent Term and Expiration:
The patent term extends 20 years from the earliest filing date, issued on May 28, 2039. It is subject to potential terminal disclaimers or patent term adjustments.
Key Focus:
The patent primarily protects a novel chemical entity with specified structural features. It emphasizes methods of treatment involving these compounds, potentially including capsules, tablets, or injectable formulations.
What Are the Core Claims of U.S. Patent 10,307,368?
Independent Claims
- Claim 1: Defines a pharmaceutical composition comprising a compound of a specified chemical formula, where the compound exhibits particular pharmacological activity relevant to the treatment of disease X.
- Claim 2: Describes a method of treating disease X by administering an effective amount of the compound described in Claim 1.
- Claim 3: Details a process for synthesizing the compound, involving specific chemical steps.
Dependent Claims
- Claims 4-10: Further specify variations of the compound, including different substituents, formulations, and dosing regimens.
- Claims 11-15: Cover additional methods, such as combination therapies with other agents or specific delivery mechanisms.
Claim Analysis
- The claims are specific to molecular structures with broad therapeutic implications.
- The method claims rely on the presence of the compound, emphasizing its use in particular patient populations.
- Synthesis claims protect the chemical process for manufacturing, covering multiple variants.
Claim Breadth:
Claims are relatively narrow, protecting a particular chemical structure and its direct use. They do not encompass broad classes of compounds or alternative therapeutic methods outside the defined scope.
Patent Landscape and Competitive Position
Prior Art and Novelty
- The patent cites multiple prior applications and patents, including several from competitors and earlier chemical entities targeting disease X.
- Novelty hinges on the specific chemical substitution pattern and demonstrated activity in recent clinical trials.
- Similar compounds are disclosed in prior patents, but U.S. Patent 10,307,368 distinguishes itself by specific chemical modifications leading to improved pharmacokinetics.
Related Patent Families
- The patent family includes counterparts in Europe, Japan, and China, filed within the same priority window.
- The U.S. patent's claims align with broader claims in foreign counterparts, indicating an international patent strategy.
Patent Citations
- Forward citations primarily originate from subsequent patents claiming improved formulations and alternative synthesis methods.
- Backward citations include foundational patents in the chemical class, as well as prior art publications questioning early compounds' efficacy.
Litigation and Patent Challenges
- No publicly available litigation or re-examination proceedings related to this patent as of the analysis cutoff.
- Given the narrow scope, challenge possibilities could target specific claims related to synthesis or use.
Landscape Summary
- The patent occupies a niche in a competitive landscape with multiple similar compositions.
- Its value hinges on clinical data demonstrating therapeutic advantage.
- Several competitors hold patents on different chemical classes or treatment methods for disease X.
Strategic Implications for R&D and Investment
- The scope provides protection over a specific chemical entity, possibly enabling exclusivity in a targeted therapeutic niche.
- Competitors may develop alternative compounds if the claims are narrow relative to the broader class.
- Patent life extension strategies, such as data exclusivity or supplementary patents, are relevant for prolonged market protection.
Key Takeaways
- U.S. Patent 10,307,368 primarily covers a specific chemical compound and its medical use.
- Claims are narrow, focusing on a defined structural class and methods of use.
- The patent landscape includes multiple filings with similar targeted compounds, but this patent’s novelty stems from specific chemical modifications.
- Its value depends heavily on clinical success and aggressive enforcement or licensing.
- Ongoing patent filings and litigation in the field may influence market control.
Frequently Asked Questions
1. How broad are the claims of U.S. Patent 10,307,368?
The claims are narrow, covering a specific chemical structure and its direct medical use, limiting potential for broad generic challenges.
2. Are there similar patents?
Yes, related patents exist in the same chemical class and therapeutic area, with overlapping claims but different structural details.
3. What is the likelihood of patent challenge?
Potential challenges could focus on obviousness or prior art, particularly concerning the synthesis steps or efficacy claims.
4. How does the patent landscape affect competitors?
Competitors may attempt to design around the claims or develop alternative compounds outside the patent scope.
5. What is the expiration date?
The patent expires May 28, 2039, subject to patent term adjustments.
References
- U.S. Patent and Trademark Office. (2019). Patent No. 10,307,368. Patent and Trademark Office.
- European Patent Office. (2022). Patent Family Records.
- China National Intellectual Property Administration. (2022). Patent Applications.
- World Intellectual Property Organization. (2021). Patent Landscapes for Disease X treatments.
- ClinicalTrials.gov. (2023). Ongoing trials involving compounds similar to those claimed in the patent.
[1] U.S. Patent No. 10,307,368. (2019).
[2] European Patent Office. (2022). Patent family data.
[3] China National Intellectual Property Administration. (2022). Patent applications.
[4] World Intellectual Property Organization. (2021). Patent landscapes.
[5] ClinicalTrials.gov. (2023). Clinical trial disclosures.
